News from the healthcare data industry
The Oncology Research Information Exchange Network (ORIEN) has grown to an alliance of 18 cancer centers, powered by the informatics platform of M2GEN, a company that spun out of Florida-based...
Industry veteran brings longstanding track record of growing innovative healthcare technology and service organizations from early-stage startup through category leadership October 21, 2022 08:05 AM Eastern Daylight Time MOUNTAIN VIEW,...
Tempus, a leader in artificial intelligence and precision medicine, today announced additional funding of approximately $275 million through a combination of equity from existing investors, which Tempus sold at the...
A vendor agnostic platform for hosting clinical AI solutions with the goal of streamlining workflow, reducing physician burnout, and improving clinical outcomes CAMBRIDGE, Mass., Oct. 20, 2022 /PRNewswire/ — TeraRecon, an industry leader...
The Research Institute of the McGill University Health Centre (RI-MUHC), in partnership with the Faculty of Medicine and Health Sciences (FMHS) and the Departments of Surgery and Medicine at McGill...
Join IQVIA experts as they explore the impact of the Observational Health Data Sciences & Informatics (OHDSI) network in key clinical studies and regulatory decisions, and how IQVIA’s partnership has...
Researchers can now run complex data analytics and artificial intelligence/machine learning using TriNetX to unlock new opportunities with remarkable clinical detail CAMBRIDGE, Mass., Oct. 20, 2022 /PRNewswire/ — TriNetX, the global network...
DENVER, Oct. 19, 2022 /PRNewswire/ — Palantir Technologies Inc. (NYSE: PLTR) announced four new additions to its Palantir Federal Advisory Board (PFAB). The additions will bring expert perspectives to the Advisory Board on...
ESTERO, Fla. and DENVER, Oct. 19, 2022 /PRNewswire/ — Hertz (NASDAQ: HTZ) and Palantir Technologies Inc. (NYSE: PLTR, “Palantir”), a leading builder of operating systems for the modern enterprise, today announced a multi-year partnership to help...
As announced in the Federal Register notice published on October 20, 2022, FDA is conducting an Advancing Real-World Evidence (RWE) Program, which seeks to improve the quality and acceptability of...